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Summary 
Objective: Following a sudden death at a residential care unit, the Dutch Health and 
Care Inspectorate advised to intensify the use of video monitoring (VM) at the unit. 
We assessed whether VM resulted in increased identification of seizures requiring 
clinical intervention. 
Methods: The unit provides care for 340 individuals with refractory epilepsy and 
severe learning disabilities. Acoustic detection systems (ADS) cover all, 37 people 
also have a bed motion sensor (BMS) and 46 people with possible nocturnal 
seizures are now monitored by VM. During a six month period, in all cases of a 
suspected seizure we asked the caregivers to specify which device alerted them and 
to indicate whether this led to an intervention. Staff costs of VM were estimated 
using payroll information.    
Results: We identified 1208 seizures in 37 individuals; four had no nocturnal 
seizures; 393 (33%) seizures were only seen on video. In 169 of 1208 (14%) 
seizures an intervention was made and this included 39 of 393 (10%) seizures only 
seen on video.  
When compared to seizures observed with an ADS or BMS, seizures only seen on 
video were more often tonic seizures (71% versus 22%, p<0.001) and occurred 
mostly in the beginning or at the end of the night (40% versus 26%, p<0.001). The 
extra staff costs of monitoring was 7,035 euro per seizure only seen on video and 
leading to an intervention. 
Significance: VM facilitates nocturnal surveillance, but the costs are high. This 
underscores the need for development of reliable seizure detection devices. 
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Key point box:  
• Video monitoring is particularly helpful to detect tonic seizures. 
• Video monitoring may also help to detect seizures late in the evening or in  
early morning, most likely due to background noise drowning out seizure noises, 
making acoustic detection systems less reliable  
• Video monitoring may facilitate detection of seizures requiring intervention 
• Video monitoring may be effective to detect clinically relevant seizures but 
costs are high. This emphasizes the need for reliable seizure detection devices  
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Introduction 
Sudden unexpected death in epilepsy (SUDEP) happens mostly after unwitnessed, 
nocturnal convulsions (1-3). Night supervision seems to be associated with a lower 
risk(4). At a boarding school for pupils with epilepsy all SUDEPs occurred when 
students were unsupervised (5) suggesting that surveillance is protective for high-
risk populations.  
Various seizures detection systems have been promoted, including acoustic devices, 
mattress sensors, video detection systems and wearables recording electrodermal 
activity, heart rate, muscle activity or movement (accelerometry)(6-9). It is, however, 
unclear which device can detect nocturnal seizures most accurately and whether this 
can reduce SUDEP risk(10, 11). 
Following a SUDEP at our residential care facility, the Dutch Health and Care 
Inspectorate advised intensification of video monitoring (VM). It is likely that VM may 
facilitate seizure detection, but the clinical relevance is not established.   
To quantify the benefits of additional nocturnal VM, we assessed whether nocturnal 
VM resulted in an increase in seizures requiring nursing intervention (e.g. emergency 
medication).  
 
Methods 
Study population 
SEIN has a residential care facility housing 340 people with refractory epilepsy and 
severe learning disabilities. Residents are supported by care staff trained to 
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recognize seizures and administrate rescue medication if required. Each resident 
has a seizure diary which is updated contemporaneously.  
Various monitoring devices are used: all have an acoustic detection system (ADS) 
(DeHeerMedicom, Born, The Netherlands), and some have a bed motion sensor 
(BMS) (Epicare 3000, Danish Care Technology, Sorø, Denmark) or a video 
monitoring system (DeHeerMedicom, Born, The Netherlands). ADS and BMS 
detection thresholds are individually set.   
There are six seizure monitoring units, each staffed with up to four caregivers. Each  
receives data from up to 80 people: up to 80 ADSs, up to 10 BMSs and up to 16 
video feeds. One person monitors all systems in units with up to 12 video feeds. In 
units with over 12 video feeds, two monitor the systems. Roles are rotated every 1.5 
hours. Those not on monitoring duty perform physical checks. When a seizure is 
suspected, the resident is contacted through an intercom system. If there is no 
response, a caregiver will determine if assistance is required. 
After the Inspectorate advice, new criteria for VM were formulated. It was 
recommended for all with (1) putative evidence of unwitnessed nocturnal convulsions 
such as incontinence or a tongue bite on awakening and (2) convulsions in the late 
evening or early morning as the ADS is less reliable then due to background noise of 
people getting ready for bed / getting out of bed. Up to 80 ADSs are monitored by 
one person and sounds made by a subject can drown out seizure-related noises of 
another. The number of video-monitored residents increased from 12 to 46, leading 
to an increment of night staff from 20 to 24 per shift. 
All these 46 residents were asked to participate. Informed consent was obtained 
from or in some cases assent was obtained from legal guardians for those who 
Commented [l1]: This is not needed to understand the 
paper! Carers are trained!!!! 
Commented [LMvd2]:  41 of 46 consented, so I can’t say 
they all consented 
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agreed to participate. Demographic data, medications, epilepsy syndrome, duration, 
seizure types, IQ and body mass index were extracted from the notes. Seizure 
frequencies were derived from the seizure diaries.   
During a six-month period, caregivers recorded details of each nocturnal seizure in 
those monitored: time and type of seizure, detecting monitoring device, if the person 
was attended and if an intervention was required. 
Caregivers used a similar seizure classification sheet to usual care including the 
following seizure types: convulsive, tonic, myoclonic, complex partial and 
unclassified. A nursing intervention was scored when the caregiver (1) repositioned 
the subject, (2) administered rescue medication, or (3) stimulated the vagal nerve 
stimulator. (see appendix A)  
All data was collected into a database (SPSS for windows, version 22) and divided 
into two groups: seizures only seen on video and seizures detected by  ADS or BMS, 
whether seen on video or not. These groups were then compared, looking for 
differences in seizure types, seizure timing and interventions performed. Actual staff 
costs were obtained from the appropriate department.  
Validation of caregiver reports 
If a seizure was suspected, staff pressed the record button thus saving ten minutes 
of video feed. A random sample of two seizures, per seizure type, per subject  was 
selected of all seizures only seen on video to validate the caregivers’ seizure 
classification. One neurologist from a panel (RDT, FC and GHV) blinded to the 
caregivers scores reviewed the videos. They recorded whether they agreed that the 
event was epileptic and classified the seizure type. They used the same seizure 
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nomenclature as the caregivers, but were asked to specify further the event type 
(e.g. hyperkinetic seizure). To score the certainty of the seizure classification and 
epileptic nature of the event a score from 1 (not certain at all) to 5 (very certain) was 
used (See appendix B). All videos for which there were doubts over the nature or 
classification (score 3 or lower) were reviewed by all three neurologists to establish a 
consensus agreement. 
BMS and ADS event logs were automatically stored. BMS logs were used to check 
whether seizures reported as being only seen on video had no matching BMS 
record. For the ADS a random sample of three nights with nocturnal events per 
subject was selected and checked for event logs of seizures reported as picked up 
by the ADS.  
Statistical analysis 
Differences between seizures only seen on video versus all other seizures were 
estimated by fitting a multivariable logistic regression model. To account for the 
correlation between seizures in the same individual we used generalized estimating 
equations (GEE). All variables were entered as predictors using a backwards 
selection procedure (p<0.05) to determine which variables are independent 
determinants of seizures detected only with help of VM. 
Results 
Forty-one of 46 people monitored were included. Five declined participation. All had 
an ADS and fourteen a BMS. General characteristics are listed in table 1. 
Reported events  
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During the six-month period caregivers reported 1260 events in 37 of the 41 
participants. No seizures were identified in four.  Fifty-two events were false positives 
as determined by the caregivers attending the individual.  
An intervention occurred in 167 of 1208 seizures. Twelve of the 37 individuals with 
nocturnal seizures did not receive an intervention. 
Characteristics of seizures only seen on video 
Caregivers reported that 393 (33%) seizures, in 29 of 37 people, were only seen on 
video. When compared to seizures observed with an ADS or BMS, seizures only 
seen on video occurred more often either at the beginning or end of the night (41% 
versus 26% of seizures, p<0.001) and were more often tonic seizures (71% versus 
22% of seizures, p<0.001).  
Convulsive seizures (CSs) and myoclonic seizures were also frequently observed 
with the ADS or BMS: 19 of 37 people had CSs seen only on video, but this was only 
12% of all detected CSs (figure 1). Seven of these 19 people had a BMS and 19 of 
these 46 convulsive seizures (41%) occurred either early morning or late evening. 
Of the 393 seizures only seen on video, 39 required an intervention (table 2) and 14 
of 29 people with seizures only seen on video had an event requiring an intervention. 
When compared to seizures only seen on video, seizures identified on an ADS or 
BMS required more interventions (16% versus 10%, p=0.006). 
When fitting a multivariable logistic regression model using generalized estimating 
equations, only three variables (seizure time, seizure type and intervention) were 
significant independent predictors. (table 3) 
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Validation of caregivers’ reports 
We randomly selected 89 videos of events only seen on video; 26 were excluded, as 
recording started too late in the seizure course to allow for a definite assumption. 
The remaining 63 were classified by the panel. 
There was agreement on the epileptic nature of the event in 58 of 63 videos (92%). 
There were some differences in the caregivers’ classification compared with those of 
the panel. Seizures classified as CSs by the caregivers were often categorized by 
the panel as focal hyperkinetic seizures.  
BMS logs were reviewed for 161 seizures only seen on video as reported by the 
caregivers. In 134 (83%) it was confirmed that the BMS did not sound in the 15 
minutes adjacent to the reported seizure onset. 
If caregivers reported that the ADS alerted them, an event could be identified in the 
log in 76 of 82 (93%) seizures between 15 minutes prior to and after the reported 
seizure onset. 
Cost-effectiveness  
Due to the increase in people video-monitored, four extra staff were required per 
night, resulting in extra yearly personnel costs of €548,762 (€274,381/ 6 months). 
We identified 393 seizures which were only seen with VM: 274,381 / 393 = €698  per 
detected seizure. Thirty-nine seizures receiving an intervention were only seen on 
video: 274,381 / 39 seizures = €7,035 per seizure and 47 CSs were only seen on 
video: 274,381 / 47 = €5,838 per seizure. 
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Discussion 
VM in conjunction with ADS and BMS facilitated nocturnal surveillance: 33% of all 
observed seizures were only seen on video. VM also helped detecting clinically 
relevant seizures: of all only seen on video, 10% required an intervention. Seizure 
timing (late night or early morning) and seizure type (tonic seizures) were 
significantly associated with seizures only seen on video. The added value of VM 
should, however, be weighed against extra costs. 
We used the caregivers’ reports as gold standard to determine which device alerted 
them to a seizure. This has implications as we cannot guarantee that all seizures 
were noticed. Those with subtle signs are likely missed but also those with obvious 
motor signs may have been ignored, as caregivers had to continuously pay attention 
to multiple video feeds and other detection devices. While we acknowledge that we 
may have underestimated the number of seizures, we did not consider screening 
videos of reported seizure free periods, as we aimed to assess the added value of 
VM and not to quantify its (obvious) limitations. Such exercise would also require 
additional EEG monitoring. A study on a similar population reported that when using 
a combination of video-EEG and accelerometry, the number of detected seizures 
was seven-fold higher than seizures seen by nurses. (6). 
Caregivers indicated which device captured a seizure. Multitasking may also have 
resulted in other alarms being ignored. We crosschecked caregivers’ reports with 
ADS and BMS event logs and agreement was good: 93% for the ADS and 83% for 
the BMS. For the ADS, though, we could not ascertain whether seizures only seen 
on video were truly silent: the system records an event for any sound above the 
threshold. Other sounds in the peri-ictal period (e.g. door shutting) may also result in 
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a data point. The same principle applies to BMSs: an alarm signal may also result 
from a subject repositioning after a seizure. No events were found in 83% of seizures 
without a staff record of a BMS alarm.   
We also relied on caregivers’ seizure classification. An expert panel, therefore, 
evaluated a random seizures subsection. We found a high agreement (92%) on the 
epileptic nature of an event between the panel and caregivers. Agreement on 
seizure type classification was, however, poor (38%), confirming previous report 
(12). The caregivers' most frequent inaccuracy was classifying “hyperkinetic focal 
seizures” as CSs. Detection systems might have the same limitation as caregivers 
judgment: a BMS will not allow differentiation between frontal lobe seizures and CSs. 
In view of the classification errors we may have overestimated the number of CSs 
that were detected by video only.  
The majority of seizures only seen on video were tonic seizures. BMSs are likely to 
miss seizures without excessive movement: a study on a BMS reported that it only 
identified three of eleven tonic seizures on an awake subject and none while 
asleep(13). A high number of seizures only seen on video were either on late 
evening or early morning. ADSs are probably less reliable during periods of high 
background noise.   
We found the greatest added value of VM to be for tonic seizures, but there is no 
evidence that these increase SUDEP risk. SUDEP was preceded by a CS in all 
monitored cases.(14)  Case control studies show a high CS frequency to be a major 
SUDEP risk factor (4, 15-17). Monitoring devices designed to detect nocturnal CSs 
may therefore decrease a person’s  SUDEP risk: people are less likely to die of 
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SUDEP when they share a room or when there is a listening device(4). An ADS is 
probably a sensitive way to detect CSs, as in 85% of CSs an ictal cry is heard (18). 
Detecting a CS that could be followed by SUDEP is no guarantee for preventing 
SUDEP. There are several reports of observed SUDEP cases, where a witness 
could not prevent it (19) and prompt resuscitation procedures  failed (11). We are 
aware of two (unpublished) cases of residents dying of SUDEP despite VM.  
Clinical implications 
VM appeared very costly: personnel outlays were estimated at €7,035 per seizure   
seen only on video and requiring an intervention. With SUDEP estimated to occur in 
1 of every 2,000 – 5,000 CSs (20), it would costs millions to detect an additional 
seizure leading to SUDEP, without guarantee that this will be preventive. We believe 
that the limited added value of VM is outweighed by the high costs. VM might 
facilitate detection of CSs as well, but this seemed often related to ADS failure or 
BMS absence. We thus do not recommend widespread VM implementation. In view 
of high costs and questionable protective effects, it seems more reasonable to 
optimize ADS or to consider other seizure detection devices. Our study underscores 
the need for the development of less costly, reliable detection devices. As those with 
intellectual disabilities have a higher seizure burden and SUDEP risk, the search for 
protective measures is even more urgent in this population (17, 21-23).  
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Figure 1: Seizures only seen on video, versus seizures observed using the ADS or BMS. 
ADS acoustic detection system; BMS bed motion sensor 
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Age (years) 37 (SD 18.3) 
Gender 
24 male / 17 
female  
Epilepsy etiology:  
Genetic 18 (44%) 
Structural metabolic 11 (27%) 
Unknown 12 (29%) 
Seizure type:  
Focal 29 (71%) 
Generalized 12 (29%) 
Age of onset (years) 4.3 (SD 4.5) 
Duration epilepsy (years) 33.1 (SD 17.7) 
Seizure type (number of 
subjects):   
Tonic seizures 20 (48.8%) 
Convulsive seizures 37 (90.2%) 
Complex partial seizures 22 (53.7%) 
Daily seizure frequency   
0 - 4 seizures / month 26 (63%) 
5 - 9 seizures / month 6 (15%) 
≥10 seizures / month 9 (22%) 
Nocturnal seizure frequency  
0 - 4 seizures / month 31 (76%) 
5 - 9 seizures / month 7 (17%) 
≥10 seizures / month 3 (7%) 
Number of AEDs  
none 2 (5%) 
1 AED 5 (12%) 
2 AEDs 11 (27%) 
3 AEDs 15 (37%) 
4 AEDs 8 (20%) 
Vagal nerve stimulator 7 (17%) 
IQ  
 ≤20 9 (22%) 
21 - 40 6 (15%) 
41 - 60 10 24%) 
61 - 80 4 (10%) 
> 80 1 (2%) 
unknown 11 (27%) 
Body Mass Index 24.2 (SD 5.8) 
Table 1: Patient characteristics (N=41) 
AED Anti-epileptic drug 
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 Seizures only seen 
on video (n = 393)  
Seizures observed with 
ADS or BMS (n = 815) 
All interventions 39 (9.9%) 128 (15.7%) 
Repositioning the 
person 
14 (3.6%) 58 (7.1%) 
Activating VNS 6 (1.5%) 6 (0.7%) 
Emergency 
medication 
17 (4.3%) 59 (7.2%) 
VNS activation 
and emergency 
medication 
2 (0.5%) 5 (0.6%) 
Table 2: Interventions 
VM video monitoring, VNS vagal nerve stimulator 
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Only seen 
on VM (n = 
393) 
Seen on an 
ADS or BMS 
(n=815) 
p-value OR 95%CI OR 
Seizure type:      
Tonic  278 (71%) 183 (22%) 0.010 2.34 1.23 – 4.46 
Other  115 (29%) 632 (78%)    
Time of seizure:      
22.30–0.00 / 6.30–8.30 
hours   160 214 <0.001 1.53 1.25 – 1.87 
0.00–6.30 hours 233 601    
      
Intervention done:      
no 354 687 0.005 0.61 0.44 – 0.86 
yes 39 128    
Table 3: Seizures only seen on VM versus all other seizures. P-value and odds 
ratios calculated using a multivariable model in generalized estimating equations. 
VM videomonitoring; ADS acoustic detection system; BMS bed motion sensor; OR 
odds ratio 
 
